Feasibility of a Resistance Exercise and Dietary Protein Intervention in Elderly People in Practice (ProMuscle 65PK)
Not Applicable
Completed
- Conditions
- Sarcopenia
- Interventions
- Dietary Supplement: Dietary protein productsOther: Resistance exercise training
- Registration Number
- NCT02434289
- Lead Sponsor
- Wageningen University
- Brief Summary
The purpose of this pilot study is to investigate the feasibility and potential impact of a combined resistance exercise and increased protein intake intervention in (frail) elderly, in a real-life setting.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 23
Inclusion Criteria
- In home assisted (also informal care) elderly individuals, that experience loss of muscle strength
- Able to understand and perform the study procedures
Exclusion Criteria
- Type I or type II diabetes (fasted blood glucose level ≥7,0 mmol) or hypertension, unless well regulated by medication
- Diagnosed cancer or Chronic Obstructive Pulmonary Disease (COPD)
- Severe heart failure
- Renal insufficiency (eGFR <60 mL/min/1.73 m2)
- Newly placed hip/knee prosthesis (unless fully recovered), or recent surgery (stress on scar tissue)
- Allergic or sensitive for milk proteins
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Resistance exercise and protein products Resistance exercise training Practice intervention trial including resistance exercise training and intake of dietary protein products in (frail) elderly, implemented by health care professionals. Resistance exercise and protein products Dietary protein products Practice intervention trial including resistance exercise training and intake of dietary protein products in (frail) elderly, implemented by health care professionals.
- Primary Outcome Measures
Name Time Method Feasibility of intervention implementation After 12 weeks Feasibility includes acceptability, applicability, dose received and implementation integrity. Collected in both participants and implementing health care professionals
- Secondary Outcome Measures
Name Time Method Change in Quality of life, as measured by Short-Form 36 (SF-36) Baseline and 12 weeks Change in Activities of Daily Living (ADL) functioning, as measured by ADL-questionnaire Baseline and 12 weeks Change in physical performance, as measured by Short Physical performance Battery (SPPB), Timed Up-and-Go (TUG) and Six Minute Walking Test (6MWT) Baseline and 12 weeks Change in skeletal muscle mass, as measured by Dual-energy X-ray Absorptiometry (DEXA) Baseline and 12 weeks Change in muscle strength, as measured by a maximum strength test Baseline and 12 weeks
Trial Locations
- Locations (1)
Zorggroep Noordwest-Veluwe, locatie Randmeer
🇳🇱Harderwijk, Gelderland, Netherlands